Stock Track | Clover Health Soars 5.12% After-Hours on Earnings Beat and Upbeat 2026 Profitability Guidance

Stock Track02-27

Clover Health Corp (NASDAQ: CLOV) experienced a significant after-hours surge of 5.12% following the release of its fourth quarter and full-year 2025 financial results.

The company reported quarterly sales of $487.7 million, surpassing analyst estimates of $467.1 million and representing a 44.7% increase compared to the same period last year. While the quarterly loss per share of $0.10 was in line with expectations, the strong revenue performance and forward-looking guidance appear to have driven investor optimism.

Key highlights from the report include full-year 2025 revenue growth of 40.3% to $1.9 billion and a 38% increase in Medicare Advantage membership. Most notably, management provided full-year 2026 guidance projecting total revenues between $2.81 billion and $2.92 billion and, importantly, anticipating its first full year of GAAP net income profitability. The company cited improving cohort economics driven by its Clover Assistant platform and strong membership growth, including a 53% year-over-year increase in Annual Enrollment Period growth.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1170350974?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-27 05:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170350974","market":"us","top_or_hot":-1,"title":"Stock Track | Clover Health Soars 5.12% After-Hours on Earnings Beat and Upbeat 2026 Profitability Guidance","media":"Stock Track","content":"<p>Clover Health Corp (NASDAQ: CLOV) experienced a significant after-hours surge of 5.12% following the release of its fourth quarter and full-year 2025 financial results.</p><p>The company reported quarterly sales of $487.7 million, surpassing analyst estimates of $467.1 million and representing a 44.7% increase compared to the same period last year. While the quarterly loss per share of $0.10 was in line with expectations, the strong revenue performance and forward-looking guidance appear to have driven investor optimism.</p><p>Key highlights from the report include full-year 2025 revenue growth of 40.3% to $1.9 billion and a 38% increase in Medicare Advantage membership. Most notably, management provided full-year 2026 guidance projecting total revenues between $2.81 billion and $2.92 billion and, importantly, anticipating its first full year of GAAP net income profitability. The company cited improving cohort economics driven by its Clover Assistant platform and strong membership growth, including a 53% year-over-year increase in Annual Enrollment Period growth.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Clover Health Soars 5.12% After-Hours on Earnings Beat and Upbeat 2026 Profitability Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Clover Health Soars 5.12% After-Hours on Earnings Beat and Upbeat 2026 Profitability Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-27 05:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Clover Health Corp (NASDAQ: CLOV) experienced a significant after-hours surge of 5.12% following the release of its fourth quarter and full-year 2025 financial results.</p><p>The company reported quarterly sales of $487.7 million, surpassing analyst estimates of $467.1 million and representing a 44.7% increase compared to the same period last year. While the quarterly loss per share of $0.10 was in line with expectations, the strong revenue performance and forward-looking guidance appear to have driven investor optimism.</p><p>Key highlights from the report include full-year 2025 revenue growth of 40.3% to $1.9 billion and a 38% increase in Medicare Advantage membership. Most notably, management provided full-year 2026 guidance projecting total revenues between $2.81 billion and $2.92 billion and, importantly, anticipating its first full year of GAAP net income profitability. The company cited improving cohort economics driven by its Clover Assistant platform and strong membership growth, including a 53% year-over-year increase in Annual Enrollment Period growth.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CLOV","symbol_name":"Clover Health Corp","start_time":0,"source_url":"","article_id":"1170350974","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170350974","pubTimestamp":1772142169,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Clover Health Corp (NASDAQ: CLOV) experienced a significant after-hours surge of 5.12% following the release of its fourth quarter and full-year 2025 financial results.The company reported quarterly...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CLOV":"Clover Health Corp"},"translate_title":"股票追踪|Clover Health盘后飙升5.12%，因盈利超出预期和乐观的2026年盈利指引","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLOV":1},"content_text":"Clover Health Corp (NASDAQ: CLOV) experienced a significant after-hours surge of 5.12% following the release of its fourth quarter and full-year 2025 financial results.The company reported quarterly sales of $487.7 million, surpassing analyst estimates of $467.1 million and representing a 44.7% increase compared to the same period last year. While the quarterly loss per share of $0.10 was in line with expectations, the strong revenue performance and forward-looking guidance appear to have driven investor optimism.Key highlights from the report include full-year 2025 revenue growth of 40.3% to $1.9 billion and a 38% increase in Medicare Advantage membership. Most notably, management provided full-year 2026 guidance projecting total revenues between $2.81 billion and $2.92 billion and, importantly, anticipating its first full year of GAAP net income profitability. The company cited improving cohort economics driven by its Clover Assistant platform and strong membership growth, including a 53% year-over-year increase in Annual Enrollment Period growth.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1170350974","isCrawlerRequest":true}